American Gene Technologies
PrivateLast Round
Convertible Debt
Oct 31, 2023
Est. Valuation
$15.21M
Total Funding Raised
$73.73M
Company Overview
American Gene Technologies is a biotechnology company that develops gene and cell therapies aimed at curing infectious diseases, cancers, and inherited disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
American Gene Technologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
American Gene Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Oct 31, 2023 | ||||
| Series F | Sep 22, 2023 | ||||
| M&A | Aug 9, 2023 | ||||
| Series F | Apr 22, 2022 | ||||
| VC Round | Apr 15, 2021 | ||||
Series C | Nov 1, 2015 |
Key People
Founding team and executive leadership
American Gene Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Fund (An Alumni Ventures Fund) | Series D |
| ROC Venture Group | Series F |
| Ride Wave Ventures | Series F |
| NIH RADx | Grant |
| Gaingels | VC Round |
| 10X Capital Venture Acquisition Corp. III | M&A |
| Alumni Ventures | Series F, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2025
Presented at the International AIDS Society 2025 conference.
- Jul 22, 2025
Promising results from AGT103-T HIV functional cure program presented at IAS 2025.
American Gene Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about American Gene Technologies's valuation, stock price, and market status.